SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-040619
Filing Date
2021-06-15
Accepted
2021-06-15 16:43:13
Documents
1
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4235
  Complete submission text file 0001209191-21-040619.txt   5599
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
Nunn Jason Raleigh (Reporting) CIK: 0001444319 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 211019057

Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences